We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

UK to Invest £100 Million in Artificial Intelligence Research

By HospiMedica International staff writers
Posted on 13 Feb 2019
Print article
Image: The UK plans to invest USD 130 million on AI development for industries including life sciences (Photo courtesy of GEP).
Image: The UK plans to invest USD 130 million on AI development for industries including life sciences (Photo courtesy of GEP).
The government of the United Kingdom has announced it will invest USD 130 million to attract 1,000 new PhD placements at universities across the country to focus on artificial intelligence (AI) development, including for the life sciences industry.

During his visit to the World Economic Forum, held in Davos (Switzerland) during January 2019, the head of Her Majesty’s Treasury, Chancellor of the Exchequer Philip Hammond, said that the investment will help futureproof the UK economy, fund forthcoming research into life-saving technology to be used in national health service (NHS) hospitals, improve voice-recognition software for business and consumers, and help cities to protect their citizens from pollution hotspots by aiding development of early warning systems.

The investment in the life sciences sector will merge with other initiatives in the fields of big data and disruptive digital technologies designed to lure clinical trials which would adopt a system for analyzing study feasibility, and an application that links patients to available studies to gear up the enrolment and ensure continued investment in research and development (R&D) in the United Kingdom. The funding is part of the £7 billion committed to the modern Industrial Strategy in 2016, and is destined to elevate investment to R&D to a record level not seen since the 1970s.

“Britain is a great place to do business. We are leading the way in the tech revolution; the UK digital sector is now worth over £130 billion, with jobs growing at twice the rate of those in the wider economy,” said Chancellor Hammond. “We are backing British innovation to help create growth, more jobs and higher living standards. And we are determined, as we leave the EU, to make sure it remains that way. I want to ensure we remain the standard bearer, so we must invest in our new economy so that it can adapt and remain competitive.”

The UK modern Industrial Strategy faces four grand challenges. These include putting the UK at the forefront of the AI and data revolution, towards which a government office for AI has been established and a £9 million Centre for Data Ethics and Innovation has been built. The other three challenges include modernizing transportation through new electrical vehicle charging technologies and development and testing of connected and autonomous vehicles; maximizing opportunities from the global shifts to clean growth and low carbon innovation; and meeting the needs of an ageing society by harnessing the power of innovation.


Print article

Channels

Critical Care

view channel
Image: EsoGuard has demonstrated over 90% specificity and 90% sensitivity in identifying Barrett’s Esophagus (Photo courtesy of Lucid Diagnostics)

Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer

Barrett's esophagus (BE) is the benign and treatable precursor condition to esophageal adenocarcinomas (EAC) which is usually diagnosed at an advanced stage and is difficult to treat. Finding BE, a sign... Read more

Surgical Techniques

view channel
Image: Bio-glue enables near-instantaneous gelling, sealing and healing of injured tissue (Photo courtesy of Pexels)

Game-Changing ‘Bio-Glue’ Could End Use of Surgical Sutures and Staple

Tissue adhesive washout and detachment are major issues for medical practitioners and may prove fatal for patients, especially when the separation happens in vital organs like the lungs, liver and the heart.... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.